Yu et al. examined SSTR subtypes in various pituitary adenomas via immunohistochemistry, finding SSTR2 staining stronger in TSHoma, acromegaly, and prolactinoma, while SSTR5 was stronger in corticotropinoma and NFPA. This evidence concerns the gene SSTR5 and non-functioning pituitary adenoma.